Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Could This Cheap COVID Vaccine Spell Doom for Pfizer and Moderna?

TheMotleyFool

0 0

Could This Cheap COVID Vaccine Spell Doom for Pfizer and Moderna?

Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) stand to make billions of dollars from their respective COVID-19 vaccines this year. The drugmakers hope to generate substantial recurring revenue going forward as well. However, a new COVID-19 vaccine is in development that could be a lot less expensive than either of these messenger RNA (mRNA) vaccines.

In this Motley Fool Live video recorded on April 7, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss whether this cheap vaccine candidate might even spell doom for Pfizer and Moderna.

Source Fool.com

Like: 0

PFE

Share